US Bancorp’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-279
| Closed | -$1.26K | – | 4216 |
|
|
2025
Q1 | $1.26K | Sell |
279
-199
| -42% | -$902 | ﹤0.01% | 3935 |
|
|
2024
Q4 | $3.38K | Hold |
478
| – | – | ﹤0.01% | 3734 |
|
|
2024
Q3 | $3.89K | Hold |
478
| – | – | ﹤0.01% | 3638 |
|
|
2024
Q2 | $3.06K | Sell |
478
-1,932
| -80% | -$12.3K | ﹤0.01% | 3611 |
|
|
2024
Q1 | $18.1K | Buy |
2,410
+1,483
| +160% | +$11.2K | ﹤0.01% | 3126 |
|
|
2023
Q4 | $8.58K | Sell |
927
-1,477
| -61% | -$13.7K | ﹤0.01% | 3348 |
|
|
2023
Q3 | $24.3K | Sell |
2,404
-1,004
| -29% | -$10.2K | ﹤0.01% | 2782 |
|
|
2023
Q2 | $42.6K | Sell |
3,408
-852
| -20% | -$10.7K | ﹤0.01% | 2558 |
|
|
2023
Q1 | $49.7K | Buy |
4,260
+1,139
| +36% | +$13.3K | ﹤0.01% | 2512 |
|
|
2022
Q4 | $33.2K | Buy |
3,121
+476
| +18% | +$5.06K | ﹤0.01% | 2728 |
|
|
2022
Q3 | $26K | Buy |
2,645
+1,902
| +256% | +$18.7K | ﹤0.01% | 2885 |
|
|
2022
Q2 | $11K | Sell |
743
-8,517
| -92% | -$126K | ﹤0.01% | 3317 |
|
|
2022
Q1 | $242K | Buy |
9,260
+1,139
| +14% | +$29.8K | ﹤0.01% | 1858 |
|
|
2021
Q4 | $322K | Sell |
8,121
-1,555
| -16% | -$61.7K | ﹤0.01% | 1757 |
|
|
2021
Q3 | $483K | Sell |
9,676
-424
| -4% | -$21.2K | ﹤0.01% | 1532 |
|
|
2021
Q2 | $560K | Sell |
10,100
-86
| -0.8% | -$4.77K | ﹤0.01% | 1491 |
|
|
2021
Q1 | $477K | Buy |
10,186
+523
| +5% | +$24.5K | ﹤0.01% | 1526 |
|
|
2020
Q4 | $421K | Sell |
9,663
-546
| -5% | -$23.8K | ﹤0.01% | 1530 |
|
|
2020
Q3 | $374K | Buy |
10,209
+10,040
| +5,941% | +$368K | ﹤0.01% | 1482 |
|
|
2020
Q2 | $5K | Buy |
+169
| New | +$5K | ﹤0.01% | 3237 |
|